1-5 of 5
H. Van Deventer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB-743921 Dosed Q14D without and with Prophylactic G-CSF in Non-Hodgkin (NHL) or Hodgkin Lymphoma (HL).

Owen A O'Connor, J. Gerecitano, H. Van Deventer, B. Afanasyev, J. Hainsworth, M. Chen, K. Saikali, J. Seroogy, R. Escandon, A. Wolff, MG. Conlan
Journal: Blood
Blood (2009) 114 (22): 1673.
https://doi.org/10.1182/blood.V114.22.1673.1673
Published: 2009
Journal Articles

A Phase I/II Trial of the Kinesin Spindle Protein (KSP) Inhibitor SB- 743921 Administered on Days 1 and 15 Every 28 Days without and with Prophylactic G-CSF in Non-Hodgkin or Hodgkin Lymphoma.

John Gerecitano, O. O’Connor, H. Van Deventer, J. Hainsworth, J. Leonard, A. Goy, B. Afanasyev, M. Chen, K. Saikali, M. G Conlan, R Escandon, A Wolff
Journal: Blood
Blood (2008) 112 (11): 1563.
https://doi.org/10.1182/blood.V112.11.1563.1563
Published: 2008
Journal Articles

Up-regulation of HIV coreceptors CXCR4 and CCR5 on CD4 + T cells during human endotoxemia and after stimulation with (myco)bacterial antigens: the role of cytokines

Nicole P. Juffermans, William A. Paxton, Pascale E. P. Dekkers, Annelies Verbon, Evert de Jonge, Peter Speelman, Sander J. H. van Deventer, Tom van der Poll
Journal: Blood
Blood (2000) 96 (8): 2649–2654.
https://doi.org/10.1182/blood.V96.8.2649
Published: 2000
Journal Articles

The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation

Rendrik F. Franco, Evert de Jonge, Pascale E. P. Dekkers, Janneke J. Timmerman, C. Arnold Spek, Sander J. H. van Deventer, Peter van Deursen, Liesbeth van Kerkhoff, Bob van Gemen, Hugo ten Cate, Tom van der Poll, Pieter H. Reitsma
Journal: Blood
Blood (2000) 96 (2): 554–559.
https://doi.org/10.1182/blood.V96.2.554
Published: 2000
Journal Articles

Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia

Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, C. Erik Hack, Susan K. Paulson, Aziz Karim, Jozef Kesecioglu, Marcel Levi, Sander J. H. van Deventer, Tom van der Poll
Journal: Blood
Blood (2000) 95 (4): 1124–1129.
https://doi.org/10.1182/blood.V95.4.1124.002k20_1124_1129
Published: 2000